Data I/O (DAIO) Competitors $3.19 0.00 (0.00%) As of 12:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DAIO vs. NAUT, PRE, INTT, OPXS, ODYS, AKYA, OMIC, OPTX, AATC, and CLIRShould you be buying Data I/O stock or one of its competitors? The main competitors of Data I/O include Nautilus Biotechnology (NAUT), Prenetics Global (PRE), inTEST (INTT), Optex Systems (OPXS), Odysight.ai (ODYS), Akoya Biosciences (AKYA), Singular Genomics Systems (OMIC), Syntec Optics (OPTX), Autoscope Technologies (AATC), and ClearSign Technologies (CLIR). These companies are all part of the "measuring and control equipment" industry. Data I/O vs. Its Competitors Nautilus Biotechnology Prenetics Global inTEST Optex Systems Odysight.ai Akoya Biosciences Singular Genomics Systems Syntec Optics Autoscope Technologies ClearSign Technologies Nautilus Biotechnology (NASDAQ:NAUT) and Data I/O (NASDAQ:DAIO) are both small-cap measuring and control equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, risk, analyst recommendations and valuation. Is NAUT or DAIO more profitable? Nautilus Biotechnology has a net margin of 0.00% compared to Data I/O's net margin of -12.21%. Data I/O's return on equity of -14.56% beat Nautilus Biotechnology's return on equity.Company Net Margins Return on Equity Return on Assets Nautilus BiotechnologyN/A -31.87% -27.39% Data I/O -12.21%-14.56%-10.84% Does the media favor NAUT or DAIO? In the previous week, Data I/O had 1 more articles in the media than Nautilus Biotechnology. MarketBeat recorded 5 mentions for Data I/O and 4 mentions for Nautilus Biotechnology. Nautilus Biotechnology's average media sentiment score of 0.94 beat Data I/O's score of 0.60 indicating that Nautilus Biotechnology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nautilus Biotechnology 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Data I/O 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation & earnings, NAUT or DAIO? Data I/O has higher revenue and earnings than Nautilus Biotechnology. Data I/O is trading at a lower price-to-earnings ratio than Nautilus Biotechnology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNautilus BiotechnologyN/AN/A-$70.78M-$0.54-1.37Data I/O$21.77M1.35-$3.09M-$0.29-11.00 Do institutionals & insiders hold more shares of NAUT or DAIO? 50.7% of Nautilus Biotechnology shares are held by institutional investors. Comparatively, 37.0% of Data I/O shares are held by institutional investors. 41.1% of Nautilus Biotechnology shares are held by insiders. Comparatively, 7.3% of Data I/O shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Do analysts prefer NAUT or DAIO? Nautilus Biotechnology currently has a consensus target price of $2.13, suggesting a potential upside of 187.94%. Data I/O has a consensus target price of $5.22, suggesting a potential upside of 63.64%. Given Nautilus Biotechnology's higher possible upside, equities research analysts clearly believe Nautilus Biotechnology is more favorable than Data I/O.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nautilus Biotechnology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Data I/O 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Which has more volatility and risk, NAUT or DAIO? Nautilus Biotechnology has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500. Comparatively, Data I/O has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. SummaryData I/O beats Nautilus Biotechnology on 8 of the 15 factors compared between the two stocks. Get Data I/O News Delivered to You Automatically Sign up to receive the latest news and ratings for DAIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DAIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DAIO vs. The Competition Export to ExcelMetricData I/OELEC IndustryComputer SectorNASDAQ ExchangeMarket Cap$29.48M$4.90B$28.04B$9.26BDividend YieldN/A2.97%3.14%4.03%P/E Ratio-11.0031.1032.8919.56Price / Sales1.352.211,721.36183.65Price / CashN/A22.5237.6457.93Price / Book1.672.227.505.58Net Income-$3.09M$171.53M$779.73M$257.82M7 Day Performance3.24%-0.75%-0.69%-0.39%1 Month Performance13.12%3.04%4.86%7.80%1 Year Performance14.75%-6.28%52,755.66%12.95% Data I/O Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DAIOData I/O1.6071 of 5 stars$3.19flat$5.22+63.6%+14.7%$29.48M$21.77M-11.00100Positive NewsNAUTNautilus Biotechnology3.0396 of 5 stars$0.80-2.9%$2.13+167.0%-72.4%$103.44MN/A-1.47130News CoveragePREPrenetics Global0.9263 of 5 stars$8.01+0.1%$9.00+12.4%+33.7%$97.64M$30.62M-2.011INTTinTEST3.7543 of 5 stars$7.32+2.5%$12.00+63.9%-37.7%$91.46M$127.50M31.83320OPXSOptex Systems2.3308 of 5 stars$11.94-0.7%N/A+67.2%$83.16M$33.99M16.8280Positive NewsODYSOdysight.ai1.8985 of 5 stars$4.70-3.1%$10.00+112.8%N/A$79.14M$3.96M-4.6140Gap UpAKYAAkoya Biosciences1.9994 of 5 stars$1.29-5.1%$2.51+94.3%N/A$67.94M$81.67M-1.3390OMICSingular Genomics SystemsN/A$20.01flat$6.50-67.5%N/A$50.83M$2.91M-0.57220OPTXSyntec Optics0.536 of 5 stars$1.38+0.7%N/A-34.3%$50.26M$29.44M0.003Positive NewsAATCAutoscope Technologies1.9144 of 5 stars$7.50flatN/A+19.9%$41.18M$12.89M8.5240CLIRClearSign Technologies2.4536 of 5 stars$0.54flat$2.00+272.4%-36.8%$28.16M$3.60M-4.4810 Related Companies and Tools Related Companies Nautilus Biotechnology Competitors Prenetics Global Competitors inTEST Competitors Optex Systems Competitors Odysight.ai Competitors Akoya Biosciences Competitors Singular Genomics Systems Competitors Syntec Optics Competitors Autoscope Technologies Competitors ClearSign Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DAIO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredAll New Social Security Numbers coming July 23?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Data I/O Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Data I/O With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DAIO Stock Alerts